About Us Services Careers FAQ Contact Us 0
Home Technology Point-of-Care Data Management Software Market Size, Share Report by 2033
Point-of-Care Data Management Software Market

Point-of-Care Data Management Software Market Size, Share & Trends Analysis Report By End-User (Hospitals/Critical Care Units, Diagnostic Centers, Clinics/Outpatient), By Applications (Infectious Disease Devices, Glucose Monitoring, Coagulation Monitoring, Urinalysis, Cardiometabolic Monitoring, Cancer Markers, Hematology, Other POC Applications) and By Region(North America, Europe, APAC, Middle East and Africa, LATAM) Forecasts, 2025-2033

Report Code: SRTE2516DR
Last Updated : March 27, 2025
Author : Chetan Patil
Starting From
USD 2300
Buy Now
File Formats

Table Of Content

  1. Executive Summary
    1. Research Objectives
    2. Limitations & Assumptions
    3. Market Scope & Segmentation
    4. Currency & Pricing Considered
    1. Emerging Regions / Countries
    2. Emerging Companies
    3. Emerging Applications / End Use
    1. Drivers
    2. Market Warning Factors
    3. Latest Macro Economic Indicators
    4. Geopolitical Impact
    5. Technology Factors
    1. Porters Five Forces Analysis
    2. Value Chain Analysis
    1. North America
    2. Europe
    3. APAC
    4. Middle East and Africa
    5. LATAM
  2. ESG Trends
    1. Global Point-of-Care Data Management Software Market Introduction
    2. By End-User
      1. Introduction
        1. End-User By Value
      2. Hospitals/Critical Care Units
        1. By Value
      3. Diagnostic Centers
        1. By Value
      4. Clinics/Outpatient
        1. By Value
    3. By Applications
      1. Introduction
        1. Applications By Value
      2. Infectious Disease Devices
        1. By Value
      3. Glucose Monitoring
        1. By Value
      4. Coagulation Monitoring
        1. By Value
      5. Urinalysis
        1. By Value
      6. Cardiometabolic Monitoring
        1. By Value
      7. Cancer Markers
        1. By Value
      8. Hematology
        1. By Value
      9. Other POC Applications
        1. By Value
    1. Introduction
    2. By End-User
      1. Introduction
        1. End-User By Value
      2. Hospitals/Critical Care Units
        1. By Value
      3. Diagnostic Centers
        1. By Value
      4. Clinics/Outpatient
        1. By Value
    3. By Applications
      1. Introduction
        1. Applications By Value
      2. Infectious Disease Devices
        1. By Value
      3. Glucose Monitoring
        1. By Value
      4. Coagulation Monitoring
        1. By Value
      5. Urinalysis
        1. By Value
      6. Cardiometabolic Monitoring
        1. By Value
      7. Cancer Markers
        1. By Value
      8. Hematology
        1. By Value
      9. Other POC Applications
        1. By Value
    4. U.S.
      1. By End-User
        1. Introduction
          1. End-User By Value
        2. Hospitals/Critical Care Units
          1. By Value
        3. Diagnostic Centers
          1. By Value
        4. Clinics/Outpatient
          1. By Value
      2. By Applications
        1. Introduction
          1. Applications By Value
        2. Infectious Disease Devices
          1. By Value
        3. Glucose Monitoring
          1. By Value
        4. Coagulation Monitoring
          1. By Value
        5. Urinalysis
          1. By Value
        6. Cardiometabolic Monitoring
          1. By Value
        7. Cancer Markers
          1. By Value
        8. Hematology
          1. By Value
        9. Other POC Applications
          1. By Value
    5. Canada
    1. Introduction
    2. By End-User
      1. Introduction
        1. End-User By Value
      2. Hospitals/Critical Care Units
        1. By Value
      3. Diagnostic Centers
        1. By Value
      4. Clinics/Outpatient
        1. By Value
    3. By Applications
      1. Introduction
        1. Applications By Value
      2. Infectious Disease Devices
        1. By Value
      3. Glucose Monitoring
        1. By Value
      4. Coagulation Monitoring
        1. By Value
      5. Urinalysis
        1. By Value
      6. Cardiometabolic Monitoring
        1. By Value
      7. Cancer Markers
        1. By Value
      8. Hematology
        1. By Value
      9. Other POC Applications
        1. By Value
    4. U.K.
      1. By End-User
        1. Introduction
          1. End-User By Value
        2. Hospitals/Critical Care Units
          1. By Value
        3. Diagnostic Centers
          1. By Value
        4. Clinics/Outpatient
          1. By Value
      2. By Applications
        1. Introduction
          1. Applications By Value
        2. Infectious Disease Devices
          1. By Value
        3. Glucose Monitoring
          1. By Value
        4. Coagulation Monitoring
          1. By Value
        5. Urinalysis
          1. By Value
        6. Cardiometabolic Monitoring
          1. By Value
        7. Cancer Markers
          1. By Value
        8. Hematology
          1. By Value
        9. Other POC Applications
          1. By Value
    5. Germany
    6. France
    7. Spain
    8. Italy
    9. Russia
    10. Nordic
    11. Benelux
    12. Rest of Europe
    1. Introduction
    2. By End-User
      1. Introduction
        1. End-User By Value
      2. Hospitals/Critical Care Units
        1. By Value
      3. Diagnostic Centers
        1. By Value
      4. Clinics/Outpatient
        1. By Value
    3. By Applications
      1. Introduction
        1. Applications By Value
      2. Infectious Disease Devices
        1. By Value
      3. Glucose Monitoring
        1. By Value
      4. Coagulation Monitoring
        1. By Value
      5. Urinalysis
        1. By Value
      6. Cardiometabolic Monitoring
        1. By Value
      7. Cancer Markers
        1. By Value
      8. Hematology
        1. By Value
      9. Other POC Applications
        1. By Value
    4. China
      1. By End-User
        1. Introduction
          1. End-User By Value
        2. Hospitals/Critical Care Units
          1. By Value
        3. Diagnostic Centers
          1. By Value
        4. Clinics/Outpatient
          1. By Value
      2. By Applications
        1. Introduction
          1. Applications By Value
        2. Infectious Disease Devices
          1. By Value
        3. Glucose Monitoring
          1. By Value
        4. Coagulation Monitoring
          1. By Value
        5. Urinalysis
          1. By Value
        6. Cardiometabolic Monitoring
          1. By Value
        7. Cancer Markers
          1. By Value
        8. Hematology
          1. By Value
        9. Other POC Applications
          1. By Value
    5. Korea
    6. Japan
    7. India
    8. Australia
    9. Taiwan
    10. South East Asia
    11. Rest of Asia-Pacific
    1. Introduction
    2. By End-User
      1. Introduction
        1. End-User By Value
      2. Hospitals/Critical Care Units
        1. By Value
      3. Diagnostic Centers
        1. By Value
      4. Clinics/Outpatient
        1. By Value
    3. By Applications
      1. Introduction
        1. Applications By Value
      2. Infectious Disease Devices
        1. By Value
      3. Glucose Monitoring
        1. By Value
      4. Coagulation Monitoring
        1. By Value
      5. Urinalysis
        1. By Value
      6. Cardiometabolic Monitoring
        1. By Value
      7. Cancer Markers
        1. By Value
      8. Hematology
        1. By Value
      9. Other POC Applications
        1. By Value
    4. UAE
      1. By End-User
        1. Introduction
          1. End-User By Value
        2. Hospitals/Critical Care Units
          1. By Value
        3. Diagnostic Centers
          1. By Value
        4. Clinics/Outpatient
          1. By Value
      2. By Applications
        1. Introduction
          1. Applications By Value
        2. Infectious Disease Devices
          1. By Value
        3. Glucose Monitoring
          1. By Value
        4. Coagulation Monitoring
          1. By Value
        5. Urinalysis
          1. By Value
        6. Cardiometabolic Monitoring
          1. By Value
        7. Cancer Markers
          1. By Value
        8. Hematology
          1. By Value
        9. Other POC Applications
          1. By Value
    5. Turkey
    6. Saudi Arabia
    7. South Africa
    8. Egypt
    9. Nigeria
    10. Rest of MEA
    1. Introduction
    2. By End-User
      1. Introduction
        1. End-User By Value
      2. Hospitals/Critical Care Units
        1. By Value
      3. Diagnostic Centers
        1. By Value
      4. Clinics/Outpatient
        1. By Value
    3. By Applications
      1. Introduction
        1. Applications By Value
      2. Infectious Disease Devices
        1. By Value
      3. Glucose Monitoring
        1. By Value
      4. Coagulation Monitoring
        1. By Value
      5. Urinalysis
        1. By Value
      6. Cardiometabolic Monitoring
        1. By Value
      7. Cancer Markers
        1. By Value
      8. Hematology
        1. By Value
      9. Other POC Applications
        1. By Value
    4. Brazil
      1. By End-User
        1. Introduction
          1. End-User By Value
        2. Hospitals/Critical Care Units
          1. By Value
        3. Diagnostic Centers
          1. By Value
        4. Clinics/Outpatient
          1. By Value
      2. By Applications
        1. Introduction
          1. Applications By Value
        2. Infectious Disease Devices
          1. By Value
        3. Glucose Monitoring
          1. By Value
        4. Coagulation Monitoring
          1. By Value
        5. Urinalysis
          1. By Value
        6. Cardiometabolic Monitoring
          1. By Value
        7. Cancer Markers
          1. By Value
        8. Hematology
          1. By Value
        9. Other POC Applications
          1. By Value
    5. Mexico
    6. Argentina
    7. Chile
    8. Colombia
    9. Rest of LATAM
    1. Point-of-Care Data Management Software Market Share By Players
    2. M&A Agreements & Collaboration Analysis
    1. Siemens Healthineers AG + (Conworx)
      1. Overview
      2. Business Information
      3. Revenue
      4. ASP
      5. SWOT Analysis
      6. Recent Developments
    2. Abbott Point of Care Inc. + (Alere)
    3. Danaher Company (HemoCue and Radiometer Medical ApS)
    4. Roche Diagnostics Corporation
    5. TELCOR Inc.
    6. Orchard Software Corporation
    7. Randox Laboratories Ltd
    8. Thermo Fisher Scientific Inc
    1. Research Data
      1. Secondary Data
        1. Major secondary sources
        2. Key data from secondary sources
      2. Primary Data
        1. Key data from primary sources
        2. Breakdown of primaries
      3. Secondary And Primary Research
        1. Key industry insights
    2. Market Size Estimation
      1. Bottom-Up Approach
      2. Top-Down Approach
      3. Market Projection
    3. Research Assumptions
      1. Assumptions
    4. Limitations
    5. Risk Assessment
    1. Discussion Guide
    2. Customization Options
    3. Related Reports
  3. Disclaimer

Related Reports

Global Report
The global contract management software market size was valued at USD 965.25 billion in 2021. It is expected to reach USD 2,940.36 billion by 2030, growing at a CAGR of 13.2% during the forecast period (2022–2030). Contract lifecycle managemen
Buy Now
Global Report
The global enterprise IP management software market size was valued at USD 5.37 billion in 2023. It is estimated to reach USD 23.45 billion by 2032, growing at a CAGR of 17.8% during the forecast period (2024–2032)
Buy Now
Global Report
The global farm management software market size was valued at USD 2.4 billion in 2022. It is projected to reach USD 8.84 billion by 2031, growing at a CAGR of 15.6% during the forecast period (2023–2031). Farm operations an
Buy Now
Global Report
Market OverviewThe global integrated risk management software market size was valued at USD 10.9 billion in 2023 and is projected to reach USD 12.5 billion by 2032, registering a CAGR of 15.1% during the forecast period (2024-2032). Rising cybercrime
Buy Now
Global Report
The global tax management software market size was valued at USD 22.19 billion in 2022 and is expected to reach USD 59.11 billion by 2031, with a CAGR of 11.5%. The tax management software calculates and creates customer-centric statements and
Buy Now

Purchase Benefits

  • Eligible for a free updated report next year
  • Completely customizable scope
  • 30% discount on your next purchase
  • Dedicated account manager
  • Query resolution within 24 hours
  • Permission to print the report

We are featured on :

www.straitsresearch.com
© Copyright 2025. All rights Reserved.